GSE240439 decitabine 1 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE240439_decitabine_1_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE240439_decitabine_1_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE240439_decitabine_1_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE240439_decitabine_1_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

WD repeat domain 46

Gene

small nucleolar RNA host gene 1

Gene

differentiation antagonizing non-protein coding RNA

Gene

small nucleolar RNA host gene 3

Gene

small nucleolar RNA host gene 16

Gene

uncharaterized LOC112694756

Gene

small nucleolar RNA host gene 4

Gene

deleted in lymphocytic leukemia 1

Gene

uncharacterized LOC102724843

Gene

H3 clustered histone 15

  • Gene

    WD repeat domain 46


  • Gene

    small nucleolar RNA host gene 1


  • Gene

    differentiation antagonizing non-protein coding RNA


  • Gene

    small nucleolar RNA host gene 3


  • Gene

    small nucleolar RNA host gene 16


  • Gene

    uncharaterized LOC112694756


  • Gene

    small nucleolar RNA host gene 4


  • Gene

    deleted in lymphocytic leukemia 1


  • Gene

    uncharacterized LOC102724843


  • Gene

    H3 clustered histone 15

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.